Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › AR › Little Rock › NPI 1477549756
Hospital

University of Arkansas for Medical Sciences

University of Arkansas for Medical Sciences was paid $87.19M by Medicaid between Jan 2018 and Dec 2024, across 664 billing codes. Its largest line is J9271, Injection, pembrolizumab, 1 mg — 10% of everything it billed.

33Billing provider infoUNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES
LITTLE ROCK, AR 72205
33aNPI1477549756assigned 09/22/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$87.19M
24GClaims3,583,453
24DCodes billed664
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Arkansas

Rank by total paid#1 of 49
Median peer was paid$2.62M
This provider vs. median33×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official GEORGE, AMANDA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$1.0M$2.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018498,994$9.32M
2019545,700$12.41M
2020479,335$12.06M
2021496,031$13.21M
2022558,025$16.03M
2023558,768$14.27M
2024incomplete446,600$9.89M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
J9271 Injection, pembrolizumab, 1 mg 10% 1,900 1,384 $8.85M
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 4.8% 49,398 34,568 $4.20M
J2350 Injection, ocrelizumab, 1 mg 4.6% 474 299 $4.03M
T1015 A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive 2.9% 237,100 178,927 $2.49M
59025 Fetal non-stress test 2.8% 18,437 11,279 $2.48M
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 2.1% 5,567 5,118 $1.83M
74177 Computed tomography, abdomen and pelvis; with contrast material 1.7% 12,949 11,512 $1.47M
80048 Basic metabolic panel (calcium, ionized) 1.6% 120,071 80,590 $1.38M
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 1.5% 33,371 30,587 $1.33M
J9312 Injection, rituximab, 10 mg 1.5% 691 274 $1.31M
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 1.5% 32,553 29,869 $1.29M
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 1.4% 7,593 6,586 $1.19M
652 more codes
J2505 Injection, pegfilgrastim, 6 mg 1.3% 1,205 $1.14M
78815 Positron emission tomography (PET) for limited area imaging 1.2% 1,679 $1.06M
78816 1.2% 1,578 $1.05M
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 1.2% 34,382 $1.01M
71260 Computed tomography, thorax, diagnostic; with contrast material 1.1% 7,361 $918K
80053 Comprehensive metabolic panel 1.0% 61,252 $901K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 7,755 $832K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 14,665 $830K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r <1% 11,299 $809K
70450 Computed tomography, head or brain; without contrast material <1% 9,244 $783K
94761 <1% 51,422 $779K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 5,908 $767K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 20,297 $764K
86901 <1% 33,198 $740K
J1726 Injection, hydroxyprogesterone caproate, (makena), 10 mg <1% 1,045 $737K
85027 <1% 117,695 $724K
74183 <1% 1,526 $708K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 113,651 $705K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 63,418 $686K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 20,431 $626K
36415 Collection of venous blood by venipuncture <1% 45,597 $614K
84443 Thyroid stimulating hormone (TSH) <1% 35,598 $598K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 6,760 $570K
J1459 Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg <1% 896 $564K
71275 Computed tomographic angiography, chest, with contrast material <1% 2,945 $550K
J0585 Injection, onabotulinumtoxina, 1 unit <1% 3,982 $543K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 2,392 $529K
72125 Computed tomography, cervical spine; without contrast material <1% 4,793 $521K
86780 <1% 31,169 $505K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 52,428 $505K
70551 Magnetic resonance imaging, brain; without contrast material <1% 2,237 $474K
62370 <1% 2,427 $470K
87150 <1% 9,917 $468K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 11,031 $455K
72141 <1% 2,096 $453K
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 10,371 $445K
82247 <1% 51,886 $434K
70496 <1% 2,959 $431K
83615 <1% 55,911 $399K
70498 <1% 2,720 $399K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 19,084 $385K
80051 <1% 28,847 $368K
84450 <1% 58,292 $365K
72156 <1% 1,038 $361K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 5,685 $358K
64642 <1% 1,650 $350K
87340 <1% 30,057 $347K
83735 <1% 70,933 $336K
82565 <1% 46,188 $332K
96375 Therapeutic injection; each additional sequential IV push <1% 6,634 $327K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 9,597 $324K
76811 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed <1% 3,281 $315K
84075 <1% 50,862 $314K
36430 <1% 2,715 $313K
84460 <1% 51,118 $313K
86803 <1% 21,976 $312K
87086 Culture, bacterial; quantitative colony count, urine <1% 37,030 $307K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries <1% 4,082 $307K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 1,268 $299K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 2,112 $296K
82310 <1% 32,511 $281K
64615 <1% 1,363 $275K
71046 Radiologic examination, chest; 2 views <1% 20,989 $271K
70491 <1% 2,327 $261K
99499 <1% 15,193 $255K
84484 <1% 32,568 $254K
83036 Hemoglobin; glycosylated (A1C) <1% 29,702 $253K
87536 <1% 3,878 $251K
J1725 Injection, hydroxyprogesterone caproate, 1 mg <1% 373 $251K
80061 Lipid panel <1% 24,893 $242K
87486 <1% 7,538 $242K
87581 <1% 7,533 $242K
82977 <1% 37,048 $236K
83880 <1% 9,703 $235K
80050 General health panel <1% 5,663 $231K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 6,368 $223K
72157 <1% 673 $221K
86762 <1% 12,109 $215K
67028 Intravitreal injection of a pharmacologic agent <1% 944 $210K
49083 <1% 1,335 $207K
J7307 Etonogestrel (contraceptive) implant system, including implant and supplies <1% 359 $206K
96361 Intravenous infusion, hydration; each additional hour <1% 3,286 $199K
72146 <1% 940 $198K
84100 <1% 65,393 $197K
81025 <1% 27,564 $194K
96367 <1% 1,582 $192K
20552 <1% 1,187 $190K
74174 <1% 1,024 $189K
77067 Screening mammography, bilateral, including computer-aided detection <1% 4,203 $182K
36591 <1% 5,367 $179K
J2506 Injection, pegfilgrastim, excludes biosimilar, 0.5 mg <1% 192 $175K
73221 <1% 901 $171K
71250 <1% 2,273 $170K
72158 <1% 486 $166K
70486 <1% 1,619 $163K
80074 <1% 3,396 $155K
83021 <1% 7,488 $154K
82728 <1% 13,663 $153K
81002 <1% 39,768 $150K
38222 <1% 1,494 $148K
88185 <1% 3,320 $146K
84520 <1% 35,238 $146K
82962 <1% 39,541 $145K
86900 <1% 33,187 $145K
82607 <1% 12,841 $144K
86850 <1% 32,880 $143K
96415 <1% 2,867 $141K
81001 <1% 41,775 $141K
C1769 Guide wire <1% 1,259 $139K
88184 <1% 7,042 $138K
97161 <1% 2,990 $136K
72197 <1% 273 $133K
J9310 Injection, rituximab, 100 mg <1% 82 $133K
76830 Ultrasound, transvaginal <1% 2,948 $132K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 3,493 $132K
64405 <1% 904 $131K
J9035 Injection, bevacizumab, 10 mg <1% 76 $130K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 2,404 $129K
64616 <1% 623 $128K
93308 <1% 3,478 $125K
71045 Radiologic examination, chest; single view <1% 17,011 $125K
87497 <1% 6,721 $122K
87077 <1% 12,021 $122K
J1650 Injection, enoxaparin sodium, 10 mg <1% 8,873 $122K
88142 <1% 7,709 $120K
J0475 Injection, baclofen, 10 mg <1% 1,197 $117K
31575 <1% 940 $115K
J0185 Injection, aprepitant, 1 mg <1% 1,161 $114K
83970 <1% 5,890 $114K
82784 <1% 9,164 $107K
93975 <1% 2,652 $104K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 2,293 $101K
84466 <1% 11,097 $99K
90715 <1% 4,990 $99K
J1050 Injection, medroxyprogesterone acetate, 1 mg <1% 1,798 $99K
95700 <1% 841 $99K
95713 <1% 653 $96K
J9299 Injection, nivolumab, 1 mg <1% 41 $96K
88307 <1% 1,758 $95K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,310 $93K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 2,091 $93K
J7050 Infusion, normal saline solution, 250 cc <1% 5,254 $93K
77066 Tomosynthesis, mammo <1% 1,558 $93K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 677 $92K
85610 <1% 23,678 $91K
84439 <1% 10,508 $90K
J7297 Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg <1% 152 $88K
83690 <1% 15,031 $88K
82570 <1% 23,170 $86K
88341 <1% 1,371 $85K
86140 <1% 16,856 $81K
87522 Neg quan hep c or qual rna <1% 2,952 $81K
82950 <1% 13,293 $80K
76820 <1% 1,535 $80K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 4,963 $79K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 3,174 $78K
90686 <1% 6,941 $77K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 2,214 $75K
Q3014 Telehealth originating site facility fee <1% 19,439 $75K
87040 <1% 6,346 $73K
86920 <1% 1,988 $73K
94010 <1% 4,191 $73K
J9145 Injection, daratumumab, 10 mg <1% 65 $72K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis <1% 432 $69K
86704 <1% 7,322 $68K
76821 <1% 1,308 $68K
0001A <1% 3,272 $67K
86706 <1% 8,285 $67K
76642 <1% 2,924 $66K
84702 <1% 6,700 $66K
73630 <1% 3,553 $65K
96377 <1% 540 $65K
76536 <1% 2,377 $64K
99285 Emergency room visit (most serious) <1% 8,106 $64K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 2,844 $64K
J9045 Injection, carboplatin, 50 mg <1% 951 $63K
82040 <1% 7,169 $63K
94729 <1% 3,249 $62K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 5,364 $61K
0002A <1% 2,931 $60K
J7120 Ringers lactate infusion, up to 1000 cc <1% 4,097 $60K
97001 <1% 1,437 $59K
97162 <1% 1,080 $59K
88342 <1% 3,018 $59K
86334 <1% 4,890 $58K
94726 <1% 3,158 $58K
82232 <1% 2,787 $58K
51798 <1% 641 $57K
92134 <1% 7,778 $56K
99283 Emergency room visit (moderate) <1% 5,389 $56K
82746 <1% 5,287 $56K
80197 <1% 14,386 $56K
83605 <1% 5,563 $56K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 4,321 $56K
84156 <1% 19,165 $55K
J1745 Injection, infliximab, excludes biosimilar, 10 mg <1% 43 $54K
83521 <1% 2,750 $54K
84165 <1% 7,119 $54K
77065 Tomosynthesis, mammo <1% 1,263 $54K
87070 <1% 4,711 $53K
73130 <1% 3,142 $53K
83540 <1% 11,209 $52K
87186 <1% 8,358 $51K
81003 <1% 26,442 $51K
73562 <1% 2,175 $51K
82248 <1% 12,910 $50K
93351 <1% 421 $50K
J3489 Injection, zoledronic acid, 1 mg <1% 338 $49K
72195 <1% 263 $47K
73590 <1% 2,581 $47K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 10,111 $45K
73610 <1% 3,066 $44K
J9041 Injection, bortezomib, 0.1 mg <1% 347 $44K
80047 <1% 1,680 $44K
87205 <1% 9,775 $43K
90677 <1% 402 $43K
86709 <1% 4,858 $43K
76801 <1% 1,272 $43K
73030 <1% 2,814 $42K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 1,573 $42K
97165 <1% 879 $42K
87507 <1% 161 $42K
72131 <1% 467 $41K
J2323 Injection, natalizumab, 1 mg <1% 15 $41K
99284 Emergency room visit (serious) <1% 5,242 $40K
82947 <1% 7,446 $40K
J2916 Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg <1% 1,572 $40K
87641 <1% 1,858 $40K
73502 <1% 2,276 $39K
80076 <1% 4,175 $39K
87631 <1% 632 $38K
J0485 Injection, belatacept, 1 mg <1% 924 $38K
84145 <1% 2,309 $37K
86235 <1% 1,139 $37K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 11,423 $36K
82951 <1% 2,172 $36K
82435 <1% 6,171 $36K
82077 <1% 2,945 $36K
72100 <1% 2,001 $36K
73560 <1% 2,083 $35K
84403 <1% 1,611 $34K
80164 <1% 2,476 $34K
84153 <1% 2,301 $33K
64483 <1% 192 $33K
84132 <1% 6,043 $33K
64644 <1% 156 $33K
76604 <1% 2,221 $32K
82105 <1% 2,479 $32K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 1,622 $32K
87177 <1% 3,100 $32K
82805 <1% 1,321 $32K
31579 <1% 203 $32K
82533 <1% 1,897 $31K
85007 <1% 11,405 $31K
86038 <1% 3,264 $30K
85730 <1% 5,890 $30K
43235 <1% 214 $30K
86923 <1% 2,712 $30K
85379 <1% 3,363 $30K
73552 <1% 1,991 $29K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 252 $29K
84295 <1% 6,337 $29K
36592 <1% 1,005 $28K
86160 <1% 3,476 $28K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 18,564 $28K
84550 <1% 8,198 $28K
82043 <1% 5,946 $27K
87305 <1% 3,629 $26K
82670 <1% 962 $26K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 823 $26K
10060 <1% 157 $26K
92557 <1% 1,688 $25K
84481 <1% 1,781 $25K
82378 <1% 1,551 $25K
95811 <1% 238 $25K
84146 <1% 1,277 $25K
31231 <1% 152 $25K
85055 <1% 2,223 $24K
80069 <1% 1,826 $24K
86592 <1% 5,807 $24K
77001 <1% 305 $24K
96417 <1% 1,049 $24K
82550 <1% 4,370 $23K
92133 <1% 3,298 $23K
J7030 Infusion, normal saline solution , 1000 cc <1% 2,334 $23K
83001 <1% 1,228 $23K
87081 <1% 2,698 $22K
83520 <1% 1,932 $22K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 5,931 $21K
77085 <1% 1,349 $21K
J2785 Injection, regadenoson, 0.1 mg <1% 431 $20K
71020 <1% 1,711 $20K
72170 <1% 1,441 $20K
64400 <1% 139 $19K
52000 <1% 170 $19K
86225 <1% 2,020 $19K
97003 <1% 493 $19K
64493 <1% 100 $19K
93971 <1% 502 $19K
36593 <1% 117 $19K
86922 <1% 453 $18K
96376 <1% 3,149 $17K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 99 $17K
74230 <1% 802 $17K
86480 <1% 282 $16K
J7060 5% dextrose/water (500 ml = 1 unit) <1% 1,054 $16K
85652 <1% 7,428 $16K
95951 <1% 252 $16K
J0640 Injection, leucovorin calcium, per 50 mg <1% 215 $16K
99152 <1% 2,138 $16K
C8929 Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography <1% 308 $15K
82375 <1% 1,316 $15K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 10,598 $15K
J1953 Injection, levetiracetam, 10 mg <1% 654 $15K
91320 <1% 309 $14K
94760 <1% 906 $14K
11100 <1% 114 $14K
87449 <1% 2,395 $14K
85384 <1% 1,729 $14K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 162 $14K
88720 <1% 2,465 $14K
V2632 Posterior chamber intraocular lens <1% 118 $14K
82330 <1% 1,662 $14K
72190 <1% 687 $14K
77063 Screening digital breast tomosynthesis, bilateral <1% 1,837 $13K
71271 <1% 353 $13K
G0202 Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (cad) when performed <1% 339 $13K
88313 <1% 2,232 $13K
86870 <1% 1,163 $13K
82575 <1% 874 $13K
82140 <1% 1,905 $13K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 13,432 $13K
92611 <1% 819 $13K
93270 <1% 612 $13K
76937 <1% 1,454 $13K
76819 Fetal biophysical profile; without non-stress testing <1% 863 $12K
87210 <1% 2,538 $12K
86481 <1% 1,155 $12K
93296 <1% 1,083 $12K
85046 <1% 3,253 $12K
J9263 Injection, oxaliplatin, 0.5 mg <1% 45 $12K
74178 <1% 132 $12K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 502 $12K
G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) <1% 573 $12K
90670 <1% 314 $12K
73110 <1% 622 $11K
87799 <1% 4,765 $11K
72040 <1% 620 $11K
80143 <1% 885 $11K
77062 <1% 226 $11K
82952 <1% 2,157 $11K
51701 <1% 140 $11K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 678 $11K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 1,178 $11K
J1453 Injection, fosaprepitant, 1 mg <1% 406 $11K
36561 <1% 51 $11K
85097 <1% 234 $11K
58100 <1% 69 $10K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 672 $10K
90870 <1% 509 $10K
80179 <1% 786 $10K
G0008 Administration of influenza virus vaccine <1% 2,344 $10K
73090 <1% 691 $9K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 1,174 $9K
77061 <1% 247 $9K
99401 <1% 985 $9K
J3475 Injection, magnesium sulfate, per 500 mg <1% 3,621 $9K
87493 <1% 355 $9K
92083 <1% 1,289 $9K
71270 <1% 49 $9K
76770 <1% 361 $9K
86696 <1% 518 $9K
99153 Mod sedat endo service >5yrs <1% 1,600 $9K
84134 <1% 1,091 $9K
80185 <1% 689 $8K
87015 <1% 1,168 $8K
74018 <1% 681 $8K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 112 $8K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 3,066 $8K
88311 <1% 1,235 $7K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 697 $7K
J3480 Injection, potassium chloride, per 2 meq <1% 3,438 $7K
69210 <1% 86 $7K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 289 $7K
91200 <1% 760 $7K
83883 <1% 504 $7K
86304 <1% 361 $7K
82610 <1% 1,124 $7K
92567 <1% 958 $7K
J7298 Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg <1% 14 $7K
77084 <1% 44 $7K
88304 <1% 286 $7K
G0475 Hiv antigen/antibody, combination assay, screening <1% 3,281 $6K
0004A <1% 748 $6K
77003 <1% 125 $6K
87102 <1% 586 $6K
83050 <1% 1,295 $6K
73060 <1% 444 $6K
87075 <1% 651 $6K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 9,580 $6K
95886 <1% 198 $6K
96401 <1% 249 $6K
80178 <1% 932 $6K
90746 <1% 199 $6K
83002 <1% 307 $6K
82150 <1% 1,088 $6K
88172 <1% 107 $5K
64643 <1% 171 $5K
76514 <1% 489 $5K
J0897 Injection, denosumab, 1 mg <1% 13 $5K
86695 <1% 518 $5K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 47 $5K
86593 <1% 1,086 $5K
87147 <1% 657 $5K
87517 <1% 259 $5K
73080 <1% 333 $5K
86146 <1% 168 $5K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 7,604 $5K
G0378 Hospital observation service, per hour <1% 7,042 $5K
M0247 Intravenous infusion, sotrovimab, includes infusion and post administration monitoring <1% 20 $5K
88264 <1% 41 $5K
76512 <1% 162 $5K
0071A <1% 118 $5K
82374 <1% 1,107 $5K
86147 <1% 152 $5K
87206 <1% 1,030 $5K
J9267 Injection, paclitaxel, 1 mg <1% 302 $5K
J3370 Injection, vancomycin hcl, 500 mg <1% 2,484 $4K
96368 <1% 81 $4K
92136 <1% 298 $4K
87184 <1% 591 $4K
J0692 Injection, cefepime hydrochloride, 500 mg <1% 823 $4K
85014 <1% 2,007 $4K
73700 <1% 43 $4K
87116 <1% 518 $4K
86800 <1% 307 $4K
85018 <1% 2,148 $4K
84480 <1% 274 $4K
G0204 Diagnostic mammography, including computer-aided detection (cad) when performed; bilateral <1% 108 $4K
0124A <1% 267 $4K
0054A <1% 238 $4K
86431 <1% 789 $4K
84154 <1% 357 $4K
95874 <1% 488 $4K
0003A <1% 236 $4K
80195 <1% 293 $4K
90732 <1% 565 $3K
72128 <1% 28 $3K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 30 $3K
C1726 Catheter, balloon dilatation, non-vascular <1% 83 $3K
72202 <1% 334 $3K
J9190 Injection, fluorouracil, 500 mg <1% 610 $3K
0072A <1% 75 $3K
84681 <1% 196 $3K
J0690 Injection, cefazolin sodium, 500 mg <1% 5,390 $3K
51702 <1% 58 $3K
64635 <1% 17 $3K
82803 <1% 177 $3K
97166 <1% 63 $3K
J1644 Injection, heparin sodium, per 1000 units <1% 3,616 $3K
90636 <1% 39 $3K
84703 <1% 452 $3K
90480 <1% 160 $3K
76775 <1% 219 $3K
72070 <1% 173 $3K
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) <1% 56 $3K
89051 <1% 532 $3K
93356 <1% 170 $3K
93017 <1% 134 $3K
57454 <1% 12 $3K
71010 <1% 346 $3K
82103 <1% 292 $3K
82010 <1% 349 $3K
J1447 Injection, tbo-filgrastim, 1 microgram <1% 22 $3K
88173 <1% 225 $3K
J1750 Injection, iron dextran, 50 mg <1% 19 $2K
J1815 Injection, insulin, per 5 units <1% 2,160 $2K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 2,577 $2K
11102 <1% 29 $2K
86376 <1% 210 $2K
J0561 Injection, penicillin g benzathine, 100,000 units <1% 41 $2K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 138 $2K
84432 <1% 141 $2K
62323 <1% 16 $2K
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) <1% 17 $2K
86200 <1% 187 $2K
19083 <1% 13 $2K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 11,194 $2K
77080 <1% 57 $2K
J2060 Injection, lorazepam, 2 mg <1% 2,065 $2K
J0780 Injection, prochlorperazine, up to 10 mg <1% 3,353 $2K
86335 <1% 167 $2K
84300 <1% 614 $2K
M0239 Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring <1% 19 $2K
86301 <1% 157 $2K
85396 <1% 525 $2K
86832 <1% 84 $2K
94060 <1% 43 $2K
92015 Determination of refractive state <1% 3,838 $2K
J2790 Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) <1% 21 $2K
90656 <1% 149 $2K
86833 <1% 84 $1K
J1170 Injection, hydromorphone, up to 4 mg <1% 4,689 $1K
96411 <1% 36 $1K
83930 <1% 239 $1K
95911 <1% 54 $1K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 10,913 $1K
80156 <1% 112 $1K
76882 <1% 119 $1K
87902 <1% 28 $1K
93454 <1% 19 $1K
74022 <1% 60 $1K
86902 <1% 172 $1K
88312 <1% 122 $1K
93458 <1% 16 $1K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 3,172 $1K
93321 <1% 43 $1K
P9040 Red blood cells, leukocytes reduced, irradiated, each unit <1% 74 $1K
J1790 Injection, droperidol, up to 5 mg <1% 1,537 $1K
J1940 Injection, furosemide, up to 20 mg <1% 2,100 $1K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 114 $1K
72082 <1% 42 $1K
86352 <1% 401 $1K
88237 <1% 15 $1K
10005 <1% 15 $1K
J2270 Injection, morphine sulfate, up to 10 mg <1% 6,142 $968.53
85049 <1% 375 $948.80
88108 <1% 71 $930.88
43762 <1% 14 $919.68
0225U <1% 1,154 $882.72
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 121 $878.97
95813 <1% 15 $813.93
82390 <1% 136 $807.72
0064A <1% 90 $803.90
G2066 Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results <1% 210 $766.90
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 2,883 $758.70
83090 <1% 63 $735.57
83516 <1% 258 $722.61
0012A <1% 160 $702.28
J2550 Injection, promethazine hcl, up to 50 mg <1% 928 $702.04
83010 <1% 62 $696.56
93297 <1% 148 $681.42
80177 <1% 158 $654.01
J2997 Injection, alteplase recombinant, 1 mg <1% 33 $644.19
0011A <1% 167 $641.31
11900 <1% 16 $640.01
92250 <1% 92 $623.63
84166 <1% 64 $622.18
84155 <1% 107 $584.78
80158 <1% 61 $581.20
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg <1% 198 $564.43
85613 <1% 111 $552.06
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 483 $525.38
82274 <1% 26 $511.06
J8540 Dexamethasone, oral, 0.25 mg <1% 2,307 $501.00
95910 <1% 13 $483.94
87324 <1% 107 $482.40
72083 <1% 15 $433.76
92020 <1% 119 $426.59
90662 <1% 821 $415.25
73551 <1% 45 $409.82
A4648 Tissue marker, implantable, any type, each <1% 14 $403.22
G0257 Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility <1% 111 $395.20
0031A <1% 20 $369.20
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 997 $365.08
95970 <1% 77 $344.11
83525 <1% 36 $331.92
86364 <1% 28 $325.20
J1250 Injection, dobutamine hydrochloride, per 250 mg <1% 388 $324.11
76857 <1% 15 $321.00
86705 <1% 51 $309.88
86039 <1% 44 $302.86
74000 <1% 18 $300.00
J0461 Injection, atropine sulfate, 0.01 mg <1% 552 $255.52
72110 <1% 12 $243.94
85306 <1% 15 $240.79
73600 <1% 13 $240.00
89060 <1% 26 $211.16
93225 <1% 16 $202.30
82272 <1% 69 $200.80
85303 <1% 14 $197.50
73620 <1% 14 $181.41
S0164 Injection, pantoprazole sodium, 40 mg <1% 355 $173.27
84157 <1% 41 $170.00
85300 <1% 12 $169.30
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 508 $169.26
82945 <1% 42 $169.13
93280 <1% 12 $168.38
88302 <1% 15 $164.88
J2791 Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu <1% 50 $157.34
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 1,522 $149.29
87640 <1% 77 $148.46
G0123 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision <1% 110 $142.60
80202 <1% 20 $135.38
93242 <1% 15 $126.64
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program <1% 10,140 $117.86
J0360 Injection, hydralazine hcl, up to 20 mg <1% 295 $106.39
86708 <1% 133 $91.93
92610 <1% 32 $81.15
J2704 Injection, propofol, 10 mg <1% 485 $78.68
J1630 Injection, haloperidol, up to 5 mg <1% 322 $78.66
S0028 Injection, famotidine, 20 mg <1% 2,751 $78.41
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 1,147 $77.43
96379 <1% 41 $75.00
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 378 $64.85
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 955 $63.74
84133 <1% 13 $42.98
J7999 Compounded drug, not otherwise classified <1% 2,012 $42.07
94618 <1% 12 $40.08
94642 <1% 49 $36.88
J0689 Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg <1% 71 $32.69
G0328 Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous <1% 12 $31.61
J2371 Injection, phenylephrine hydrochloride, 20 micrograms <1% 334 $30.31
J1920 Injection, labetalol hydrochloride, 5 mg <1% 96 $30.23
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 146 $27.87
J0456 Injection, azithromycin, 500 mg <1% 29 $24.32
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 13 $21.14
Q9965 Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml <1% 250 $19.76
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 63 $17.44
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 200 $13.37
Q0163 Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen <1% 1,800 $3.63
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 55 $3.60
J1171 Injection, hydromorphone, 0.1 mg <1% 39 $1.28
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 1,105 $1.17
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 192 $0.83
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting <1% 326 $0.74
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals <1% 300 $0.64
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting <1% 107 $0.23
G8985 Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting <1% 31 $0.12
G8984 Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals <1% 30 $0.11
C9113 Injection, pantoprazole sodium, per vial <1% 449 $0.04
G8988 Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting <1% 24 $0.03
G8987 Self care functional limitation, current status, at therapy episode outset and at reporting intervals <1% 24 $0.03
G8996 Swallowing functional limitation, current status at therapy episode outset and at reporting intervals <1% 66 $0.02
G8997 Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting <1% 66 $0.02
Q9957 Injection, perflutren lipid microspheres, per ml 0% 1,047 $0.00
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 0% 206 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 0% 175 $0.00
81241 0% 15 $0.00
J0688 Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg 0% 73 $0.00
84425 0% 13 $0.00
97116 0% 22 $0.00
J3473 Injection, hyaluronidase, recombinant, 1 usp unit 0% 13 $0.00
C1887 Catheter, guiding (may include infusion/perfusion capability) 0% 14 $0.00
J0131 Injection, acetaminophen, not otherwise specified,10 mg 0% 257 $0.00
G0009 Administration of pneumococcal vaccine 0% 143 $0.00
J3490 Unclassified drugs 0% 18 $0.00
J8501 Aprepitant, oral, 5 mg 0% 46 $0.00
81240 0% 13 $0.00
94660 0% 20 $0.00
J1030 Injection, methylprednisolone acetate, 40 mg 0% 15 $0.00
86769 0% 17 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGEORGE, AMANDA (ASSOC VC FOR CLINICAL FINANCE)
Same official

Other billing entities under GEORGE, AMANDA

Full network →
ProviderLocationPaid
University of Arkansas for Medical SciencesLittle Rock, AR$54.86M
University of Arkansas for Medical SciencesLittle Rock, AR$28.66M
University of Arkansas for Medical SciencesLittle Rock, AR$27.62M
University of Arkansas for Medical SciencesPine Bluff, AR$9.95M
University of Arkansas for Medical SciencesFort Smith, AR$9.21M
University of Arkansas for Medical SciencesLittle Rock, AR$7.89M
University of Arkansas for Medical SciencesMorrilton, AR$7.69M
University of Arkansas for Medical SciencesSearcy, AR$7.13M
University of Arkansas for Medical SciencesNorth Little Rock, AR$6.55M
University of Arkansas for Medical SciencesLittle Rock, AR$6.43M
University of Arkansas for Medical SciencesPocahontas, AR$6.22M
University of Arkansas for Medical SciencesMagnolia, AR$6.11M
University of Arkansas for Medical SciencesSpringdale, AR$5.86M
University of Arkansas for Medical SciencesNewport, AR$5.13M
University of Arkansas for Medical SciencesMountain View, AR$4.96M
University of Arkansas for Medical SciencesFort Smith, AR$3.05M
University of Arkansas for Medical SciencesWarren, AR$3.03M
University of Arkansas for Medical SciencesJonesboro, AR$2.04M
University of Arkansas for Medical SciencesLittle Rock, AR$1.72M
University of Arkansas for Medical SciencesTexarkana, AR$1.52M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.